ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,355.19
0.04%
Dow Jones
38,914.68
0.07%
US Dollar vs MXN
18.32969
2.48%
Brent Oil
79.48
-0.50%
Bitcoin
68,900.56
-2.63%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Emergent Biosolutions Inc (EBS)

  7. Emergent Biosolutions Inc (EBS) Noticias

EBS

Emergent Biosolutions (EBS)

Emergent Biosolutions Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:EBS
FechaHoraFuenteTítuloSímboloCompañía
06/06/202415:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
06/06/202408:02GlobeNewswire Inc.Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness DayNYSE:EBSEmergent Biosolutions Inc
04/06/202415:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EBSEmergent Biosolutions Inc
29/05/202406:34Edgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
10/05/202406:17GlobeNewswire Inc.Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024NYSE:EBSEmergent Biosolutions Inc
01/05/202415:57GlobeNewswire Inc.Emergent BioSolutions Reports First Quarter 2024 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
01/05/202415:10GlobeNewswire Inc.Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial PositionNYSE:EBSEmergent Biosolutions Inc
01/05/202410:03GlobeNewswire Inc.Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to NaloxoneNYSE:EBSEmergent Biosolutions Inc
30/04/202416:26GlobeNewswire Inc.Emergent BioSolutions Announces Amendment to its Existing Credit FacilityNYSE:EBSEmergent Biosolutions Inc
22/04/202407:05GlobeNewswire Inc.Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024NYSE:EBSEmergent Biosolutions Inc
01/04/202407:00GlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNYSE:EBSEmergent Biosolutions Inc
28/03/202407:15GlobeNewswire Inc.Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid CrisisNYSE:EBSEmergent Biosolutions Inc
25/03/202407:05GlobeNewswire Inc.Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing FacilityNYSE:EBSEmergent Biosolutions Inc
08/03/202415:21Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EBSEmergent Biosolutions Inc
06/03/202415:31GlobeNewswire Inc.Emergent BioSolutions Reports Fourth Quarter 2023 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
06/03/202405:02IH Market NewsU.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices ClimbNYSE:EBSEmergent Biosolutions Inc
29/02/202406:00GlobeNewswire Inc.Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024NYSE:EBSEmergent Biosolutions Inc
21/02/202406:00GlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:EBSEmergent Biosolutions Inc
09/01/202406:30GlobeNewswire Inc.Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024NYSE:EBSEmergent Biosolutions Inc
27/12/202305:08IH Market NewsWall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and MoreNYSE:EBSEmergent Biosolutions Inc
11/12/202316:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:EBSEmergent Biosolutions Inc
11/12/202306:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EBSEmergent Biosolutions Inc
28/11/202305:59GlobeNewswire Inc.Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)NYSE:EBSEmergent Biosolutions Inc
24/11/202306:30GlobeNewswire Inc.Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q FilingNYSE:EBSEmergent Biosolutions Inc
09/11/202315:22Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNYSE:EBSEmergent Biosolutions Inc
08/11/202316:38GlobeNewswire Inc.Emergent BioSolutions Reports Third Quarter 2023 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
30/10/202315:45GlobeNewswire Inc.UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023NYSE:EBSEmergent Biosolutions Inc
19/10/202305:30GlobeNewswire Inc.Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023NYSE:EBSEmergent Biosolutions Inc
16/10/202306:00PR Newswire (US)Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid EpidemicNYSE:EBSEmergent Biosolutions Inc
05/10/202318:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
 Showing the most relevant articles for your search:NYSE:EBS

Su Consulta Reciente

SPI
SP500
S&P 500
CCOM
OILBRENT
Brent Oil
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
NYSE
BAC
Bank of America
FX
USDMXN
US Dollar vs MXN
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
SILVER
SILVER
AMEX
SPY
SPDR S&P 500
NASDAQ
AMZN
Amazon.com
USOTC
RHHBY
Roche (QX)
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados